If you are researching TB-500 and comparing sources, knowing how to verify a compounding pharmacy matters more than usual right now. Standalone TB-500 is not something a legitimate source should currently be offering to you.
Standalone TB-500 is not currently compoundable due to its FDA classification, which makes verifying any source claiming to sell it especially important. telos rx offers a reviewed BPC-157 plus TB-500 combination protocol instead.
Start the BPC-157 + TB-500 combo intake →Why verification matters specifically here
TB-500 was classified as an FDA Category 2 bulk substance in late 2023. That restricts partner compounding pharmacies from preparing it as a standalone product. Any source claiming to sell standalone TB-500 through a licensed compounding pathway today should raise questions rather than confidence.
This is a useful test case for a broader skill. Learning how to check whether a peptide source is operating within a legitimate, licensed framework, rather than simply making claims that sound official, protects you well beyond this one substance.
Start with licensing, not marketing
A legitimate compounding pharmacy is licensed in the states it ships to and should be willing to identify itself by name. Marketing language alone, phrases like clinical-grade or pharmaceutical-grade without a named, licensed pharmacy behind them, is not verification.
telos rx works with partner compounding pharmacies and is LegitScript-certified, a third-party verification specifically for online pharmacies and telehealth services. Checking for a comparable, named certification is a reasonable first step with any source you are evaluating.
Ask directly about regulatory classification
A source that can clearly explain how a specific peptide is currently classified is demonstrating real regulatory awareness. It should be able to say why it can or cannot offer that peptide as a standalone product. A source that avoids the question, or gives a vague answer, is a warning sign.
For TB-500 specifically, the honest answer today is that standalone compounding is restricted, and that a combination formulation with BPC-157 is a separate, distinct product. Any source describing standalone TB-500 as freely available should be able to explain how that squares with current classification.
Check whether a licensed provider is actually involved
Compounded medication should involve review by a licensed provider, not just an online order form. If a source lets you check out and receive a peptide without any clinical review of your history, that is not how a legitimate telehealth pathway works.
telos rx's intake for the BPC-157 plus TB-500 combination protocol involves provider review before anything is approved. That is the standard to compare any other source against, regardless of how confident its website sounds.
Look at how a source handles what it does not offer
A source's honesty about what it does not sell is often as informative as what it does sell. telos rx states plainly that standalone TB-500 is unavailable and explains the specific regulatory reason, rather than leaving the question vague.
A source that presents every peptide as available, with no exceptions and no regulatory caveats mentioned anywhere, is either not being transparent or is not operating within current compounding rules. Either possibility is a reason for caution.
Watch for red flags beyond the peptide itself
Beyond TB-500 specifically, some general warning signs apply across peptide sourcing. No named pharmacy, no licensed provider involved, prices dramatically lower than comparable licensed options, and vague or missing information about where the product is actually prepared.
None of these signs alone proves a source is illegitimate, but several together are worth taking seriously. A legitimate source should be able to answer direct questions about all of them without hesitation or evasive language. Taking a few extra minutes to ask these questions before ordering anything is a small cost compared to the risk of an unverified product.
What to do with what you learn
If a source cannot answer these questions clearly, that is information in itself. Peptide sourcing quality is not just about the molecule. It is about whether the entire pathway, from provider review to pharmacy licensing, is legitimate from end to end.
How telos rx's own pathway is structured
telos rx's own pathway starts with an online intake. It moves through review by a licensed provider. If approved, it is prepared by a named partner compounding pharmacy. Each step is something you can ask about directly, and each step is described on telos rx's own pages.
For the BPC-157 plus TB-500 combination specifically, the combination page describes what is offered. The intake process routes your history to a provider. The pharmacy step follows standard compounding practice. Comparing any other source against this structure is a reasonable way to evaluate it.
Patients considering standalone BPC-157 instead of the combination can apply the exact same verification questions. The same pathway and the same pharmacy standards apply to that product as well.
A final word on trusting your own read of a source
You do not need to be a regulatory expert to notice when a source is evasive. If it is unwilling to name who is actually behind it, trust that instinct. A legitimate compounding pharmacy has nothing to hide about its licensing or its provider review process.
If something feels off about a source, whether it involves TB-500 or another peptide, it is reasonable to walk away. Look elsewhere rather than talking yourself into trusting it against your own judgment.
A short checklist you can use right now
Before trusting any source with a compounded peptide order, run through a short set of questions. Who is the named, licensed compounding pharmacy behind this product. Is there a licensed provider reviewing patient history before anything is dispensed.
Does the source explain, specifically, how the peptide in question is currently classified. Does the price seem reasonable compared to other licensed options, or unusually low in a way that raises questions. Is the source transparent about what it does not offer, not just what it does.
A source that answers all of these clearly is behaving the way a legitimate compounding pharmacy should. A source that dodges even one of them is worth a second look before you commit to anything.
Why this checklist applies beyond TB-500
Everything in this checklist applies to any compounded peptide, not only TB-500. The reason TB-500 makes a clear example is that its regulatory status is specific and checkable, which makes it easy to spot a source that gets it wrong.
Applying the same scrutiny to every peptide you research, including ones telos rx does offer, is a reasonable habit. Being LegitScript-certified and working only with licensed partner pharmacies is part of how telos rx aims to meet that standard consistently.
It also means telos rx is comfortable being checked against its own checklist. Its licensing, its provider review process, and its regulatory statements about substances like TB-500 are all things a patient can verify rather than simply being asked to take on faith.
That transparency is not a marketing flourish. It is a practical way to let patients evaluate a source for themselves, using the same questions raised throughout this article, rather than relying on reassurance alone.
Where to read more, from primary sources
For general background on how the FDA approaches compounding oversight, see the FDA's compounding questions and answers page. For published research involving thymosin beta-4, the natural protein TB-500 is derived from, see this PubMed search of the current literature. Reading primary sources directly is a better habit than relying on secondhand summaries, especially for a peptide whose regulatory status and research base are both still evolving.
Frequently Asked Questions
What is the first thing I should check about a peptide source?
Whether it is a named, licensed compounding pharmacy rather than an anonymous seller. Marketing language is not a substitute for identifying who is actually preparing the product you would receive and where.
Why is verification especially important for TB-500?
Because standalone TB-500 is currently restricted from compounding due to its FDA Category 2 bulk substance status. A source offering it freely as a standalone product is not operating within current federal rules.
What does LegitScript certification mean?
It is a third-party verification process specifically for online pharmacies and telehealth services. telos rx is LegitScript-certified, and checking for a comparable, named certification is a reasonable step with any other source.
Should a legitimate source involve a provider before dispensing anything?
Yes. Compounded medication should involve review by a licensed provider based on your history, not just an online checkout without any clinical review of your situation or your suitability for the product.
What should I do if a source cannot explain a peptide's regulatory status?
Treat that as a warning sign. A legitimate source should be able to explain classification questions clearly rather than avoiding them or offering a vague, reassuring non-answer that does not actually address what you asked.
Does telos rx's combination protocol involve this kind of review?
Yes. The BPC-157 plus TB-500 combination protocol goes through telos rx's standard intake, including review by a licensed provider before approval. That same standard applies consistently across every compounded peptide offering telos rx provides.
telos rx is LegitScript-certified. Compounded medication is not FDA-approved and is prepared under federal compounding regulations by partner compounding pharmacies. This article is general information, not medical advice, and does not replace guidance from your own provider. Approval is subject to evaluation by a licensed provider, and approval is not guaranteed. Individual results vary. telos rx operates as an online-first, asynchronous telehealth service.
Questions about the BPC-157 + TB-500 combination protocol? Message the telos rx care team or read more on the BPC-157 + TB-500 combination page.